Was a good CC under tough circumstances . Company seemed intent on being fiscally responsible with the cash they have been growing and doesn't sound like they will spend foolishly trying to chase some pre approved wonder drug/co. I like that. I like the 10% no cost participation in WPI nextgen product. How long that takes to materialize is anyone ques.
Financials are decent but top line growth is not exactly exploding. They believe .02 a Q is a good benchmark to hit so I am pleased with that. That should have put us at $1 easily but in this market-cap range its all a big? I think even Frank is aware the company is snake bit.